A Phase IB/II Single-arm Study of M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas
Phase of Trial: Phase I/II
Latest Information Update: 17 Sep 2019
Price : $35 *
At a glance
- Drugs Bintrafusp alfa (Primary) ; Gemcitabine (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 13 Sep 2019 Status changed from recruiting to suspended.
- 02 May 2019 Status changed from suspended to recruiting.
- 29 Aug 2018 Status changed from recruiting to suspended as the study is undergoing sponsor audit